These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Re: clozapine--current status and role in the pharmacotherapy of schizophrenia. Sharma V Can J Psychiatry; 1996 Sep; 41(7):483. PubMed ID: 8884040 [No Abstract] [Full Text] [Related]
4. [Clozapine in the treatment of schizophrenia]. Raitasuo V Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005 [No Abstract] [Full Text] [Related]
5. Clozapine augmented with aripiprazole in 5 patients with schizophrenia. Abu-Tair F; Kopitz J; Bergemann N J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831 [No Abstract] [Full Text] [Related]
7. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine. Kumar S; Ng B; Howie W Psychiatry Clin Neurosci; 2003 Apr; 57(2):235-6. PubMed ID: 12667173 [No Abstract] [Full Text] [Related]
8. A dilemma born of progress: switching from clozapine to a newer antipsychotic. Rafal S; Tsuang MT; Carpenter WT Am J Psychiatry; 1999 Jul; 156(7):1086-90. PubMed ID: 10401457 [No Abstract] [Full Text] [Related]
11. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group. Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652 [No Abstract] [Full Text] [Related]
12. Comparison of clozapine and risperidone. Hamer RM; Simpson PM Am J Psychiatry; 2000 Feb; 157(2):310. PubMed ID: 10671435 [No Abstract] [Full Text] [Related]
13. Use of clozapine in oneroid state. Mendhekar DN J Neuropsychiatry Clin Neurosci; 2007; 19(1):85-6. PubMed ID: 17308234 [No Abstract] [Full Text] [Related]
14. Distinguishing change in primary and secondary negative symptoms. Remington G; Chong SA; Kapur S Am J Psychiatry; 1999 Jun; 156(6):974-5. PubMed ID: 10360154 [No Abstract] [Full Text] [Related]
15. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine. Friedman J; Ault K; Powchik P Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089 [No Abstract] [Full Text] [Related]
16. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms. Kämpf P; Agelink MW; Naber D Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467 [No Abstract] [Full Text] [Related]
17. Neuroleptic-resistant schizophrenia treated with clozapine and ECT. Benatov R; Sirota P; Megged S Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173 [TBL] [Abstract][Full Text] [Related]
18. Clozapine and recidivism. Gordon BJ; Milke DJ Psychiatr Serv; 1995 Oct; 46(10):1079. PubMed ID: 8829795 [No Abstract] [Full Text] [Related]
19. [Clozapine and treatment of negative symptoms]. Lançon C; Farisse J; Llorca PM Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403 [TBL] [Abstract][Full Text] [Related]
20. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]